Download PDF
Thromb Haemost 1996; 75(01): 182-189
DOI: 10.1055/s-0038-1650240
Original Article
Schattauer GmbH Stuttgart

Fibrinogen Binding to ICAM-1 on EA.hy 926 Endothelial Cells Is Dependent on an Intact Cytoskeleton

Anja van de Stolpe
1   The Department of Hematology, University Hospital Nijmegen, The Netherlands
,
Nancy Jacobs
1   The Department of Hematology, University Hospital Nijmegen, The Netherlands
,
Willem J Hage
2   The Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands
,
Leon Tertoolen
2   The Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands
,
Yvette van Kooyk
3   The Tumor Immunology Laboratory, University Hospital Nijmegen, The Netherlands
,
Irena RO Nováková
1   The Department of Hematology, University Hospital Nijmegen, The Netherlands
,
Theo de Witte
1   The Department of Hematology, University Hospital Nijmegen, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 28 April 1995

Accepted after resubmission 13 October 1995

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Fibrinogen is a ligand for Intercellular Adhesion Molecule-1 (ICAM-1), and enhances monocyte-endothelial cell interaction by coupling Mac-1 on monocytes to ICAM-1 on endothelial cells. We investigated the role of the cytoskeleton in fibrinogen binding to the human endothelial cell line EA.hy 926 using immunofluorescence techniques. In this cell line TNFα induced the simultaneous appearance of stress fibers and of ICAM-1, which was clustered predominantly on endothelial cell projections. Incubation of TNFα-stimulated endothelial cells with fibrinogen resulted in binding of fibrinogen to ICAM-1 on these cell projections. Disruption of the cytoskeleton by cytocholasin B abolished fibrinogen binding. Activation of protein kinase C with 12-O-tetradecanoyl phorbol- 13-acetate resulted in simultaneous loss of both stress fibers and fibrinogen binding. These results suggest that a connection between ICAM-1 and the cytoskeleton results in clustering of ICAM-1 on cell projections, which is required for fibrinogen binding.

 

  • References

  • 1 Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 1988; 107: 1893-1900
    CrossrefPubMedGoogle Scholar
  • 2 Gustafson EJ, Lukasiewicz HL, Wachtvogel YT, Norton KJ, Schmaier AH, Niewiarowski S, Colman RW. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. J Cell Biol 1989; 109: 377-387
    CrossrefPubMedGoogle Scholar
  • 3 Stern DP, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci USA 1985; 82: 2523-2527
    CrossrefPubMedGoogle Scholar
  • 4 Dejana E, Zanetti A, Conforti G. Biochemical and functional characteristics of fibrinogen interaction with endothelial cells. Haemostasis 1988; 18: 262-270
    PubMedGoogle Scholar
  • 5 Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC. Fibrinogen mediates leucocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993; 73: 1423-1434
    CrossrefPubMedGoogle Scholar
  • 6 Languino LR, Duperray A, Joganic KJ, Fomaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 1995; 92: 1505-1509
    CrossrefPubMedGoogle Scholar
  • 7 Pober JS, Gimbrone Jr MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-1896
    PubMedGoogle Scholar
  • 8 Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254
    PubMedGoogle Scholar
  • 9 Rothlein R, Czajkowsky M, O’Neill MM, Marlin SD, Meinolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continous cell lines by pro-inflammatory cytokines. J Immunol 1988; 141: 1665-1669
    PubMedGoogle Scholar
  • 10 Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992; 263 (Cell Physiol 32): C 767-772
    CrossrefPubMedGoogle Scholar
  • 11 Wertheimer SJ, Myers CL, Wallace RW, Parks TP. Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 1992; 267: 12030-12035
    PubMedGoogle Scholar
  • 12 van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT. 12-0-Tetradecanoylphorbol-13-acetate-and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J Biol Chem 1994; 269: 6185-6192
    PubMedGoogle Scholar
  • 13 Nagel T, Resnick WN, Atkinson WJ, Dewey Jr CF, Gimbrone Jr MA. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994; 94: 885-891
    CrossrefPubMedGoogle Scholar
  • 14 Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52: 925-933
    CrossrefPubMedGoogle Scholar
  • 15 Diamond MS, Staunton DE, Martin SD, Springer TA. Binding of the integrin Mac-1 (CD1 lb/CD 18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation of glycosylation. Cell 1991; 65: 961-971
    CrossrefPubMedGoogle Scholar
  • 16 van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141: 1427-1433
    PubMedGoogle Scholar
  • 17 Bini A, Genoglio Jr JJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Arteriosclerosis 1989; 9: 109-121
    CrossrefPubMedGoogle Scholar
  • 18 Verbeek MM, Otte-Höller I, Westphal JR, Wesseling P, Ruiter DJ, de Waal RMW. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer’s disease. Am J Pathol 1994; 144: 104-116
    PubMedGoogle Scholar
  • 19 van Horssen M, Loman S, Rijkers GT, Boom SE, Bloem AC. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling. Eur J Immunol 1995; 25: 154-158
    CrossrefPubMedGoogle Scholar
  • 20 Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987; 84: 6471-6475
    CrossrefPubMedGoogle Scholar
  • 21 Tax WJM, Willems HW, Reekers PPM, Capel PJA, Koene RAP. Polymorphism in mitogenic effect of IgGl monoclonal antibodies against T3 antigen on human T cells. Nature 1983; 304: 445-447
    CrossrefPubMedGoogle Scholar
  • 22 Edgell C-JS, Me Donald CC, Graham JB. Permanent cell line expressing human factor VUI-related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734-3737
    CrossrefPubMedGoogle Scholar
  • 23 Beretz A, Freyssinet JM, Gauchy J, Schmitt DA, Klein-Soyer C, Edgell C-JS, Cazenave J-P. Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. Biochem J 1989; 259: 35-40
    CrossrefPubMedGoogle Scholar
  • 24 Emeis JJ, Edgell C-JS. Fibrinolytic properties of a human endothelial hybrid cell line (EA.hy 926). Blood 1988; 71: 1669-1675
    PubMedGoogle Scholar
  • 25 van Ooost BA, Edgell C-JS, Hay CW, MacGillivray RTA. Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line. EA.hy 926. Biochem Cell Biol 1986; 64: 699-705
    CrossrefPubMedGoogle Scholar
  • 26 Schliwa M, Nakamura T, Porter KR, Euteneur U. A tumor promoter induces rapid and coordinated reorganization of actin and vinculin in cultured cells. J Cell Biol 1984; 99: 1045-1059
    CrossrefPubMedGoogle Scholar
  • 27 Peppelenbosch MP, Tertoolen LGJ, Hage WJ, de Laat SW. Epidermal growth factor-induced actin remodelling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 1993; 74: 565-575
    CrossrefPubMedGoogle Scholar
  • 28 White JG, Amos WB, Fordham M. An evaluation of confocal vs conventional imaging of biological structures by fluorescent light microscopy. J Cell Biol 1987; 105: 41-48
    CrossrefPubMedGoogle Scholar
  • 29 Languino LR, Colella S, Zanetti A, Andrieux A, Ryckewaert JJ, Charon MH, Marchisio PC, Plow EF, Ginsberg MH, Marguerie G, Dejana E. Fibrinogen-endothelial cell interaction in vitro: a pathway mediated by an Arg-Gly-Asp recognition specificity. Blood 1989; 73: 734-742
    PubMedGoogle Scholar
  • 30 Stolpen AA, Guinar EC, Fiers W, Pober JS. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human endothelial cell monolayers. Am J Pathol 1986; 123: 16-24
    PubMedGoogle Scholar
  • 31 Partridge CA, Horvath CJ, del Vecchio PJ, Phillips PG, Malik AB. Influence of extracellular matrix in tumor necrosis factor-induced increase in endothelial permeability. Am J Physiol 1992; 263 (Lung Cell Mol Physiol 7): L 627-633
    PubMedGoogle Scholar
  • 32 Jaken S, Leach K, Klauck T. Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J Cell Biol 1989; 109: 697-704
    CrossrefPubMedGoogle Scholar
  • 33 Nishizuka Y. Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 1989; 63: 1892-1903
    CrossrefPubMedGoogle Scholar
  • 34 Lane TA, Lamkin GE, Wancewicz EV. Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor. Biochem Biophys Res Commun 1990; 172: 1273-1281
    CrossrefPubMedGoogle Scholar
  • 35 Smith EB, Thompson WD. Fibrin as a factor in atherogenesis. Thrombosis Res 1993; 73: 01-19
    PubMedGoogle Scholar
  • 36 Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR. Structural recognition of a novel fibrinogen y chain sequence (117-133) by Intercellular Adhesion Molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 1995; 270: 696-699
    CrossrefPubMedGoogle Scholar
  • 37 Molony L, Armstrong L. Cytoskeletal reorganizations in human umbilical vein endothelial cells as a result of cytokine exposure. Exp Cell Res 1991; 196: 40-48
    CrossrefPubMedGoogle Scholar
  • 38 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex (1988). Blood 1988; 71: 831-843
    PubMedGoogle Scholar
  • 39 Altieri DC, Plescia J, Plow EF. The structural motif Glycine 190-Valine 202 of the fibrinogen y chain interacts with CD1 Ib/CD 18 integrin (aMβ2, Mac-1) and promotes leukocyte adhesion. J Biol Chem 1993; 268: 1847-1853
    PubMedGoogle Scholar
  • 40 Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC. CD 11 c/CD 18 on neutrophils recognizes a domain at the N terminus of the Aa chain of fibrinogen. Proc Natl Acad Sci USA 1991; 88: 1044-1048
    CrossrefPubMedGoogle Scholar
  • 41 Postigo AA, Corbi AL, Sanchez-Madrid F, de Landazuri MO. Regulated expression and function of CD 11 c/CD 18 integrin on human B Lymphocytes. Relation between attachments to fibrinogen and triggering of proliferation through CDllc/CD18. J Exp Med 1991; 174: 1313-1322
    CrossrefPubMedGoogle Scholar
  • 42 Martinez J, Rich E, Barsigian C. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. J Biol Chem 1989; 264: 20502-20508
    PubMedGoogle Scholar
  • 43 Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G. Tumor necrosis factor a receptor (integrin β3) and interferon γ modulate the expression of the vitronectin receptor in human endothelial cells. J Biol Chem 1991; 12: 7638-7645
    PubMedGoogle Scholar
  • 44 Nieuwenhuizen W, Haverkate F. Calcium-binding regions in fibrinogen. Ann NY Ac Sci 1983; 93-96
    PubMedGoogle Scholar
  • 45 Carpen O, Pallai P, Staunton DE, Springer TA. Association of Intercellular Adhesion Molecule-1 (ICAM-1) with actin-containing cytoskeleton and α-actinin. J Cell Biol 1992; 118: 1223-1234
    CrossrefPubMedGoogle Scholar
  • 46 Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107: 321-331
    CrossrefPubMedGoogle Scholar
  • 47 Rothlein R, Mainolfi E, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793
    PubMedGoogle Scholar
  • 48 Welder CA, Lee DHS, Takei F. Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. J Immunol 1993; 150: 2203-2210
    PubMedGoogle Scholar
  • 49 Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460-3464
    CrossrefPubMedGoogle Scholar
  • 50 Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-745
    CrossrefPubMedGoogle Scholar
  • 51 Fan S-T, Edgington TS. Coupling of the adhesive receptor CD1lb/CD 18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest 1991; 87: 50-57
    CrossrefPubMedGoogle Scholar
  • 52 Fan S-T, Edgington TS. Integrin regulation of leukocyte inflammatory functions. J Immunol 1993; 150: 2972-2980
    PubMedGoogle Scholar
  • 53 Rowland FN, Donovan MJ, Picciano PT, Wilner GD, Kreutzer DL. Fibrinmediated vascular injury. Am J Pathol 1984; 117: 418-428
    PubMedGoogle Scholar
  • 54 Dang CV, Bell WR, Kaiser D, Wong A. Disorganisation of cultured vascular endothelial monolayers by fibrinogen fragment D. Science 1985; 227: 1487-1490
    CrossrefPubMedGoogle Scholar
  • 55 van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in human: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-2526
    PubMedGoogle Scholar
  • 56 Wada H, Ohiwa M, Kaneko T, Tamaka S, Tanigawa M, Takagi M, Mori Y, Shirakawa S. Plasma level of tumor necrosis factor in disseminated intra-vascular coagulation. Am J Hemat 1991; 37: 147-151
    CrossrefPubMedGoogle Scholar
  • 57 Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Taka-hashi H, Deguchi K, Nakano T. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 1992; 40: 167-170
    CrossrefPubMedGoogle Scholar
  • 58 van de Kar NCAJ, Monnens LAH, Karmali MH, van Hinsbergh VWM. Tumor necrosis factor and interleukin-1 induce expression of the verocyto-toxin creceptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992; 80: 2755-2764
    PubMedGoogle Scholar
  • 59 Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shigha-toxin. J Clin Invest 1993; 92: 2110-2116
    CrossrefPubMedGoogle Scholar
  • 60 Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 1993; 142: 1721-1728
    PubMedGoogle Scholar